Notably, these analyses were performed on tumors harvested 2 weeks after cessation of dox stimulation of FLAG-cIKK2 expression; thus, the shift towards an anti-tumor macrophage phenotype by increased NF-κB signaling was both robust and persistent in our ovarian cancer model. The gene discussed is NFKB1; the disease is ovarian carcinoma.